Who is sponsoring NCT03970850?

NCT03970850 is sponsored by NeuMoDx Molecular, Inc..

What drugs are being tested in NCT03970850?

Interventions in NCT03970850: NeuMoDx CT/NG Assay, FDA-cleared NAATs.

What condition does NCT03970850 study?

NCT03970850 studies Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection.

Is NCT03970850 still recruiting?

NCT03970850 is currently completed. Last updated 12 June 2020.

Last reviewed 2020-06-12 · How we verify

NCT03970850

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NeuMoDx PrEDiCTiNG Study Evaluation Plan

Completed NA Last updated 12 June 2020

What this trial tests

NA trial testing NeuMoDx CT/NG Assay in Chlamydia Trachomatis Infection in 4,017 participants. Completed in 25 February 2020.

Timeline

22 July 2019

Primary endpoint
25 February 2020

25 February 2020

Quick facts

Lead sponsor	NeuMoDx Molecular, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	4,017
Start date	22 July 2019
Primary completion	25 February 2020
Estimated completion	25 February 2020
Sites	15 locations across United States

Drugs / interventions tested

NeuMoDx CT/NG Assay
FDA-cleared NAATs

Conditions studied

Chlamydia Trachomatis Infection — all drugs for Chlamydia Trachomatis Infection →
Neisseria Gonorrheae Infection — all drugs for Neisseria Gonorrheae Infection →

Sponsor

NeuMoDx Molecular, Inc.

Who can join

Adults 14 to 80, any sex, with Chlamydia Trachomatis Infection or Neisseria Gonorrheae Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This investigational study will be conducted to evaluate the performance of the NeuMoDx™ CT/NG Assay on the NeuMoDx™ 288 Molecular System and NeuMoDx™ 96 Molecular System (collectively referred to as NeuMoDx™ CT/NG Assay test system).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chlamydia Trachomatis Infection

Currently open trials in the same condition.

NCT05666778 — Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03970850 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NeuMoDx Molecular, Inc.
Last refreshed: 12 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03970850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing